AIRO Neurooncology Group

@Ithurts42 19

It's not 9, how many birds are there then???🤔

📢Join us THIS WEEK for the next #ISRSWebinar: "SBRT FOR OLIGOMETASTASES: PAST, PRESENT, FUTURE” 🗓️ Thu, 26 Jan 2023, 14:00 CET 🥼 David PALMA, MD, PHD @drdavidpalma Prof & #RadOnc, @WesternU 👉 REGISTER: bit.ly/3QVZJxb

PostOp hypofractionated stereotactic irradiation can be delivered with 25–30 Gy in 5 fractions with efficacy in excess of 82% & no significant toxicity when the dose to ‘brain−GTV’ does not exceed 20 cm3 @UZH_en @UZH_ch @ksaarau @ASTRO_org @ACRORadOnc link.springer.com/article/10.100…

How we treat primary central nervous system lymphoma - #PCNSL - which patients should be treated with HDC/ASCT? ow.ly/7h1n50GhmS0 @EANOassociation

First-in-human phase I study shows safety and potential efficacy of oral TGF-βR1 inhibitor LY3200882 for the treatment of recurrent #glioma with some PRs per RANO criteria. #btsm

Venerdì 1 ottobre ore 15:30: proseguono i venerdì di neuro-oncologia! Questa settimana IMMUNOTERAPIA E RADIOTERAPIA NEL TRATTAMENTO DELLE METASTASI DA NSCLC. Non mancate! #airocns #webinar

🎯It’s tomorrow! Join us at #EANO2021 virtual. Enjoy limitless learning with 2 days full of scientific sessions, discussions and networking events in #Neurosurgery #NeuroOncology #braintumor #RadiationTherapy #Immunotherapy #PrimaryBrainTumors #btsm @OncoAlert @OncLive

Oggi ore 15.30: immunoterapia e radioterapia nel trattamento delle metastasi da melanoma! Non mancate! #airocns

Friday September 24th Next AIRO_CNS Webinar Vi aspettiamo numerosi per discutere su #mets encefalo #SRS #Radiotherapy #immunotherapy #radonc

Learn more here about interactions among mitochondrial proteins altered in #glioblastoma @NSTumorSection #cancer #laboratory #research link.springer.com/article/10.100…

Although a #osimertinib/#bevacizumab combination was marginally effective in most #glioblastoma patients with #EGFR amplification and #EGFRvIII mutation, a subgroup experienced a long-lasting meaningful benefit. @AndresFCardonaZ @ogarrieta link.springer.com/article/10.100…

CORSO @AIRO80327989 SUI TRATTAMENTI STEREOTASSICI ABLATIVI #SBRT #SABR #oligomets #RadOnc #radonc : STATO DELL'ARTE, INDICAZIONI ED IMPLICAZIONI NELLA PRATICA CLINICA Webinar ECM. Iscrivetevi qui: 👉 ecm.radioterapiaitalia.it/front/single/11

Morphological changes after cranial fractionated photon radiotherapy. Steven Nagtegaal et al. @ctRO_journal 2021. White matter and grey matter volume loss rates ranging from 5.3 to 15.3% per 30 Gy. @UMCUtrecht @Szabolcs_David @mje_zandvoort doi.org/10.1016/j.ctro… #openaccess

Check out this analysis of patterns of failure and appraisal of postoperative radiation field for grade II–III meningioma @NSTumorSection #brain #cancer link.springer.com/article/10.100…

@AIRO_CNS @AIRO80327989 📯Next scheduled event focused on #radionecrosis #radonc #neurotwitter 🧠 🧐 🔜 📌Vi aspettiamo venerdì 10 settembre 🔜

#Leptomeningeal #metastasis often requires CSF shunting- but pt selection+goals essential. In @JNeurooncol we ID key outcome determinants: #brainmet burden, KPS++ to help guide rx decisions @MSKNeurosurgery @Dr_N_Moss @evanbanderMD @MelissaYuanMD @Anne_S_Reiner @MSKBiostats

Image-Guided Robotic Radiosurgery for the Treatment of Same Site Spinal Metastasis Recurrences pubmed.ncbi.nlm.nih.gov/34123794/

Long-term outcomes of spinal SBRT. Is it important to select the treatment time? pubmed.ncbi.nlm.nih.gov/34342817/

Classification of true progression after radiotherapy of brain metastasis on MRI using artificial intelligence: a systematic review and meta-analysis pubmed.ncbi.nlm.nih.gov/34377988/

Integration of Systemic Therapy and Stereotactic Radiosurgery for Brain Metastases pubmed.ncbi.nlm.nih.gov/34359583/